Northland Capmk Estimates Hyliion's Q3 Earnings (NYSE:HYLN)

Key Points

• Northland Capmk has revised down its Q3 2025 earnings per share estimate for Hyliion from ($0.07) to ($0.08), with further reductions in future earnings forecasts for 2026 and 2027.
• Hyliion's stock has a current market capitalization of $276.22 million and has experienced a 52-week range between $1.11 and $4.0950.
• Insider activity highlights that Director Richard Joseph Freeland purchased 65,000 shares, increasing his ownership of Hyliion stock by 41.19%.

Hyliion Holdings Corp. (NYSE:HYLN - Free Report) - Equities research analysts at Northland Capmk lowered their Q3 2025 EPS estimates for shares of Hyliion in a report issued on Wednesday, August 20th. Northland Capmk analyst E. Jackson now expects that the company will post earnings per share of ($0.08) for the quarter, down from their prior forecast of ($0.07). The consensus estimate for Hyliion's current full-year earnings is ($0.28) per share. Northland Capmk also issued estimates for Hyliion's Q4 2025 earnings at ($0.08) EPS, FY2025 earnings at ($0.34) EPS, Q3 2026 earnings at ($0.09) EPS, Q4 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.35) EPS and FY2027 earnings at ($0.34) EPS.

A number of other equities research analysts also recently weighed in on the stock. Zacks Research raised shares of Hyliion from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 13th. Wall Street Zen lowered shares of Hyliion from a "hold" rating to a "sell" rating in a research note on Sunday. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Hyliion currently has an average rating of "Hold".

Hyliion Trading Down 4.6%

Shares of HYLN traded down $0.09 during mid-day trading on Friday, reaching $1.75. The company had a trading volume of 363,576 shares, compared to its average volume of 1,355,024. Hyliion has a fifty-two week low of $1.11 and a fifty-two week high of $4.10. The stock has a market cap of $306.14 million, a price-to-earnings ratio of -4.72 and a beta of 2.73. The firm has a fifty day simple moving average of $1.53 and a 200-day simple moving average of $1.55.

Insider Transactions at Hyliion

In other news, Director Richard Joseph Freeland purchased 65,000 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average cost of $1.57 per share, with a total value of $102,050.00. Following the acquisition, the director directly owned 222,798 shares of the company's stock, valued at approximately $349,792.86. This trade represents a 41.19% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 20.90% of the stock is owned by corporate insiders.

Institutional Trading of Hyliion

Institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. increased its holdings in shares of Hyliion by 10.9% in the second quarter. JPMorgan Chase & Co. now owns 76,835 shares of the company's stock valued at $101,000 after purchasing an additional 7,574 shares during the last quarter. AQR Capital Management LLC raised its holdings in Hyliion by 15.1% in the 1st quarter. AQR Capital Management LLC now owns 76,957 shares of the company's stock valued at $108,000 after buying an additional 10,076 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Hyliion by 11.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 121,536 shares of the company's stock worth $318,000 after acquiring an additional 12,007 shares during the period. ProShare Advisors LLC increased its stake in shares of Hyliion by 47.5% in the 4th quarter. ProShare Advisors LLC now owns 39,287 shares of the company's stock valued at $103,000 after acquiring an additional 12,657 shares in the last quarter. Finally, Aquatic Capital Management LLC purchased a new position in Hyliion during the 4th quarter worth $42,000. Institutional investors own 22.81% of the company's stock.

About Hyliion